The Branded Drug Paradox: Deconstructing America’s Billion-Dollar Overspend and the Path to Competitive Advantage
"The $1 Trillion Question: How America’s Billion-Dollar Overspend on Branded Drugs is Putting Patients and Payers at Risk
As the US healthcare system grapples with rising costs and unequal access to care, a critical examination of the branded drug…